Authorization backlog at a record 162 units, up 35% sequentially
Cash utilization of $1.8 million, lowest since scale-up activities began in 2018
Conference call begins at 4:30 p.m. Eastern time today
CAMBRIDGE, Mass. (November 10, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three and nine months ended September 30, 2020. Read more.